ArticleGynecologic oncology reports2025
Adnexal mass referral patterns in Gynecologic Oncology.
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Emerging Role of Generalizable Vision-Language Models in Ovarian Cancer Diagnosis.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: There is a perceived increase in adnexal mass referrals to Gynecologic Oncology that do not meet American College of Obstetricians and Gynecologists (ACOG) referral criteria. There is little data regarding referral patterns to Gynecologic Oncology. Our primary objective is to determine the proportion of consults meeting ACOG referral criteria over an eleven year period. Methods: A retrospective chart review was conducted for adnexal mass referrals between 2011 and 2021. Variables such as age, menopausal status, imaging findings, tumor markers, surgery and histopathologic diagnosis determined whether the initial consult met ACOG referral criteria. Results: A total of 864 new consults were reviewed, 84.7 % meeting ACOG referral criteria. When broken down by year, 82.0 %, 78.9 %, 82.2 %, 86.1 %, 92.6 % met criteria for the years 2011, 2012, 2016, 2018, 2021, respectively. There was a significantly higher proportion of consults meeting referral criteria in 2021 compared to 2011 (p = 0.003). In 2011, 37.8 % of surgical cases meeting ACOG criteria were malignant compared to 45.2 % in 2021 (p = 0.145). Conclusions: Our service has seen an increasing proportion of adnexal mass referrals that meet ACOG referral criteria. There is also a trending increase in malignant histopathology. This may be due to increased scrutiny of referrals by gynecologic oncologists starting in 2016 with appropriate referral to benign gynecology. Improved scrutiny of adnexal mass referrals could decrease the number of benign cases evaluated by Gynecologic Oncology, helping preserve resources for patients with higher risk of malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.